These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node. Soni NK; Spillane AJ ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439 [TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy in breast cancer and melanoma requires adequate self-audit. Spillane A ANZ J Surg; 2004 May; 74(5):308-13. PubMed ID: 15144247 [TBL] [Abstract][Full Text] [Related]
4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
5. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912 [TBL] [Abstract][Full Text] [Related]
6. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer. Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709 [TBL] [Abstract][Full Text] [Related]
7. Safety of sentinel node biopsy in breast cancer patients who receive a second radioisotope injection after visualization failure in lymphoscintigraphy. Meretoja TJ; Joensuu H; Heikkilä PS; Leidenius MH J Surg Oncol; 2010 Nov; 102(6):649-55. PubMed ID: 20976732 [TBL] [Abstract][Full Text] [Related]
8. Selection for axillary clearance in breast cancer (ultrasound negative, sentinel node positive patients have low rates of further metastases). Nath J; Sami N; Massey J; Donnelly J; Corder AP Eur J Surg Oncol; 2013 May; 39(5):450-4. PubMed ID: 23433860 [TBL] [Abstract][Full Text] [Related]
9. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462 [TBL] [Abstract][Full Text] [Related]
10. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
11. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413 [TBL] [Abstract][Full Text] [Related]
12. [Sentinel node biopsy for breast cancer patients at the Bács-Kiskun County Teaching Hospital]. Cserni G; Rajtár M; Boross G; Sinkó M; Svébis M; Baltás B; Ambrózay E; Szúcs M Orv Hetil; 2002 Mar; 143(9):437-46. PubMed ID: 12013684 [TBL] [Abstract][Full Text] [Related]
13. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246 [TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer]. Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794 [TBL] [Abstract][Full Text] [Related]
15. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Bulte CS; van der Heiden-van der Loo M; Hennipman A Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809 [TBL] [Abstract][Full Text] [Related]
16. [Locating the sentinel node in breast cancer by gamma probe and staining agent. Preliminary study]. Vázquez Forner C; Giménez Climent J; Fliquete Peris MV; Fuster Diana C; Más Arcas C; Vázquez Albaladejo C Rev Esp Med Nucl; 2000 Jun; 19(3):207-10. PubMed ID: 11062084 [TBL] [Abstract][Full Text] [Related]
17. Medium-term follow-up data after sentinel node biopsy alone for breast cancer. Haid A; Knauer M; Köberle-Wührer R; Ammann K; Koller L; Eiter H; Lang A; Wenzl E Eur J Surg Oncol; 2006 Dec; 32(10):1180-5. PubMed ID: 16750344 [TBL] [Abstract][Full Text] [Related]
18. Discordance between number of scintigraphic and perioperatively identified sentinel lymph nodes and axillary tumour recurrence. Volders JH; van la Parra RF; Bavelaar-Croon CD; Barneveld PC; Ernst MF; Bosscha K; De Roos WK Breast; 2014 Apr; 23(2):159-64. PubMed ID: 24456968 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience]. Iannace C; Di Libero L; Lepore M; De Stefano N; Buono M; Sciascia V; Manetta F; Giordano M; Scetta G; Varriale R; Esposito D; Tartaglia E; Ferbo U; Miletto P; Caracciolo F Ann Ital Chir; 2010; 81(2):103-11; discussion 112-3. PubMed ID: 20726388 [TBL] [Abstract][Full Text] [Related]
20. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]